North America Wound Care Market Size, Share, By Product, Wound Type, End User, and By Country - Trends, Analysis, and Forecast till 2035

• North America wound care market size was worth at USD 9.5 Billion in 2024.
• The target market is projected to grow at USD 14.4 Billion in 2035.
• The market is growing at a CAGR of 4.0%.

Wound care involves keeping would clean, and covered to prevent infection. Target market is driven by the increasing number of patients suffering from chronic and acute wounds. In addition, rising healthcare expenditure, and strong presence of market players in the region are another factors propelling the market growth. Furthermore, collaborations and partnerships between companies which helps to achieve growth is also anticipated to create opportunities for growth of the global market over the forecast period.

Key Takeaways:

• The U.S. dominates the market due to increasing cases of chronic ulcers and diabetes. 
• For Instance, according to the article published in Mary Ann Liebert, Inc., chronic wounds impact the quality of life (QoL) of nearly 2.5% of the total population in the U.S.

Key Drivers of Target Market:

Increasing Cases of Chronic Diseases & Related Wounds Drives the Market Growth

Chronic diseases including as diabetes, cancer, and others, affect the natural healing ability of body. Many diseases including diabetes lower the speed of wound repair process which leads to a longstanding need for wound dressings, resulting in high demand for them, propelling the North America wound care market growth.

• For Instance, according to the data published by National Library of Medicine in 2021, one in three to one in every five patients with diabetes mellitus (DM) will develop a chronic non-healing wound in their lifetime, such as a diabetic foot ulcer (DFU), with an alarming recurrence rate of 40% within one year and 65% within five years.

Restraints:

Problems Associated with Improper Wound Care such as Infection May Hindered the Growth of Market

The biggest risk of improper wound care is infection. An infection slows the process of wound healing. While the skin is open, bacteria can enter and multiply inside, causing an infection. The infected wound will discharge pus, and can be very painful. An infection can be developed by soft tissues, bones, and organs.

• Counterbalance Statements: Proper wound care while following all the rules can lowers the risk of infection. 

Opportunities:

Advance Technologies Will Propels Market Growth in Upcoming Years

Integration of advance technologies, such as ultrasonic probes for debridement, smart beds for ulcer prevention, sensors for compression pressure monitoring, point-of-care imaging devices for bacterial management, bioelectronics devices for improving healing rates, among others will help to create future opportunities.

• For Instance, In June 2024, MTF Biologics, a global leader in tissue-based solutions, and Centurion Therapeutics, a pioneering distributor in the medical field, today announced they have entered into a new agreement that will give more clinicians and patients in complex wound settings within hospitals and post-acute care facilities access to advanced wound healing technologies.

The North America Wound Care Market is classified into product, wound type, end user, and country.

Product:

Based on the product, the North America wound care market is categorized into traditional dressings, advanced dressings, hydrofiber dressings, foam dressings, and film dressings. Among these, the advanced dressings dominates the target market as it regulates moisture levels and they have antimicrobial properties. 

• For Instance, according to the article published by Winner Medical Co., Ltd., in October 2022, advanced wound care can improve the healing process, reduces the amount of scarring and swelling, improve the quality of life for the individual who has a wound, prevent infection from developing in a wound.

Wound Type:

The North America wound care market by material type is bifurcated into chronic wounds, and acute wounds. The chronic wound are expected to dominate the target market due to aging population, increases cases of diabetes and obesity especially in children’s, etc.  

• For Instance, according to the U.S. Centers for Diseases Control and Prevention, in the U.S., in 2017-2018, about 1 in 5 school-aged children were affected by obesity among them 20.3% are 6-11 year-olds, and 21.2% are 12-19 year-olds.
• For Instance, according to 2017-2018 data from the National Health and Nutrition Examination Survey, nearly 1 in 3 adults (30.7%) are overweight, more than 2 in 5 adults (42.4%) have obesity, and about 1 in 11 adults (9.2%) have severe obesity.

End-Use Industry:

The targeted market, by end user, is classified into hospitals, specialty clinics, homecare, and others. However, hospitals segment held the largest share of the market. This is due to widespread usage, and applications.

North America Wound Care Market Report Scope:

Segmentation:

By Product:

• Traditional Dressings
• Advanced Dressings
• Hydrofiber Dressings
• Foam Dressings
• Film Dressings
• Others

By Wound Type:

• Chronic Wounds
• Acute Wounds

By End User:

• Hospitals
• Specialty Clinics
• Homecare
• Others

By Region:

• North America
  • U.S.
  • Canada

The key players operating in the North America wound care market include Johnson & Johnson Medical NV., Baxter, 3M, Convatec Group PLC, and among others. The key players are adopting strategies for the growth of the market, such as huge distribution network, strong brand reputation, key strategies, significant marketing, and fundamental investments.

List of Key Players in the Market:

• Johnson & Johnson Medical NV.
• Baxter
• 3M
• Convatec Group PLC
• INTEGRA LIFESCIENCES
• Medline Industries, LP.
• Molnylcke Health Care AB
• PAUL HARTMANN AG
• URGO MEDICAL
• Medtronic
• Holister Incorporated
• Cardinal Health

• In November 2024, BioStem Technologies Inc., a leading MedTech company, announced the signing of a Letter of Intent (LOI) to acquire commercial-stage products and development technologies from ProgenaCare Global LLC, a pioneering medical device company. The acquisition of ProgenaMatrix and revyve Antimicrobial Wound Gel reflects the Company’s continued commitment to building a diverse portfolio of complementary wound care products that enable BioStem to leverage its commercial infrastructure.
• In November 2024, SOLASCURE Ltd, a biotechnology company developing a novel treatment to transform chronic wound care and the U.S. Army Institute of Surgical Research, announced a research collaboration to evaluate SolasCure's investigational product, Aurase Wound Gel, as a means for managing combat wounds.
• In November 2024, Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular filler that could transform the way diabetic wounds are treated, potentially improving patient outcomes. 

More Related Reports

Healthcare Provider Market
Healthcare Market
AI in Healthcare Market
Digital Health Market
Big Data in Healthcare Market